Please provide your email address to receive an email when new articles are posted on . Nomacopan was well tolerated and beneficial in patients with bullous pemphigoid, according to phase 2a clinical ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Patients with bullous pemphigoid treated with IL-2 had ...
NEW YORK and LONDON, April 28, 2021 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a biopharmaceutical company focused on innovative therapeutics to treat orphan autoimmune and ...
With 1000+ market research reports and 1 billion+ data points, Future Market Insights (FMI) serves each and every requirement of the clients operating in the global healthcare, pharmaceuticals, and ...
The top 5 most-read dermatology content of 2025 on AJMC.com included innovative advances from artificial intelligence ...
Pune, Maharashtra, India, December 29 2020 (Wiredrelease) Prudour Pvt. Ltd –:Market.us newly added its expanding treasury with a new research study. The research report, entitled Bullous Pemphigoid ...
ENGLEWOOD CLIFFS, N.J., Aug. 20, 2018 (GLOBE NEWSWIRE) -- Immune Pharmaceuticals, Inc. (OTCQB: IMNP) (“Immune” or the “Company”), a biopharmaceutical company developing novel therapeutic agents for ...
A 10-year-old boy was diagnosed with B-precursor ALL at 18 months of age. After 6 months of treatment he had CNS recurrence followed shortly by a bone marrow relapse. He received standard chemotherapy ...
Bullous pemphigoid, an immune-mediated condition characterized by large, fluid-filled blisters on the skin, is a rare but serious complication of cancer therapy with immune checkpoint inhibitors (ICIs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback